AN2 Therapeutics Statistics
Total Valuation
ANTX has a market cap or net worth of $32.59 million. The enterprise value is -$34.47 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, after market close.
Earnings Date | May 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ANTX has 30.18 million shares outstanding. The number of shares has increased by 14.15% in one year.
Current Share Class | 30.18M |
Shares Outstanding | 30.18M |
Shares Change (YoY) | +14.15% |
Shares Change (QoQ) | +0.57% |
Owned by Insiders (%) | 6.65% |
Owned by Institutions (%) | 32.65% |
Float | 21.65M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.44 |
P/TBV Ratio | 0.44 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.68
Current Ratio | 8.68 |
Quick Ratio | 8.41 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -49.32% and return on invested capital (ROIC) is -32.48%.
Return on Equity (ROE) | -49.32% |
Return on Assets (ROA) | -29.49% |
Return on Invested Capital (ROIC) | -32.48% |
Return on Capital Employed (ROCE) | -65.18% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.06M |
Employee Count | 22 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.28% in the last 52 weeks. The beta is 0.01, so ANTX's price volatility has been lower than the market average.
Beta (5Y) | 0.01 |
52-Week Price Change | -49.28% |
50-Day Moving Average | 1.27 |
200-Day Moving Average | 1.21 |
Relative Strength Index (RSI) | 34.60 |
Average Volume (20 Days) | 319,101 |
Short Selling Information
The latest short interest is 42,423, so 0.14% of the outstanding shares have been sold short.
Short Interest | 42,423 |
Short Previous Month | 36,054 |
Short % of Shares Out | 0.14% |
Short % of Float | 0.20% |
Short Ratio (days to cover) | 0.31 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -47.80M |
Pretax Income | -66.03M |
Net Income | -45.35M |
EBITDA | n/a |
EBIT | -47.80M |
Earnings Per Share (EPS) | -$1.52 |
Full Income Statement Balance Sheet
The company has $67.06 million in cash and n/a in debt, giving a net cash position of $67.06 million or $2.22 per share.
Cash & Cash Equivalents | 67.06M |
Total Debt | n/a |
Net Cash | 67.06M |
Net Cash Per Share | $2.22 |
Equity (Book Value) | 73.33M |
Book Value Per Share | 2.43 |
Working Capital | 61.55M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -42.29M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |